Klasse, P. J., Sanders, R. W., Cerutti, A., & Moore, J. P. (2012). How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development? Mary Ann Liebert, Inc.
Citação norma ChicagoKlasse, Per Johan, Rogier W. Sanders, Andrea Cerutti, and John P. Moore. How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development? Mary Ann Liebert, Inc, 2012.
Citação norma MLAKlasse, Per Johan, Rogier W. Sanders, Andrea Cerutti, and John P. Moore. How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development? Mary Ann Liebert, Inc, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.